You have no items in your shopping cart.
Tybriva (Generic Imbruvica), manufactured by Emcure in India, is used to treat certain types of blood cancer in adults, including lymphoma and leukemia. This medicine is also prescribed to treat an immune system problem called chronic graft versus host disease (cGVHD). Lymphoma is a kind of cancer that affects cells in the immune system, which is the body’s defense against infection. And leukemia is a type of cancer that affects white blood cells. There are many different types of lymphoma and leukemia.
Emcure Tybriva to treat the following:
• Mantle cell lymphoma (MCL)
• Chronic lymphocytic leukemia (CLL)
• Small lymphocytic lymphoma (SLL)
• Waldenström’s macroglobulinemia (WM)
• Marginal zone lymphoma (MZL)
• Chronic Graft-versus-Host Disease (cGVHD) if at least one other systemic treatment didn’t work
Ibrutinib, the active ingredient in Tybriva capsules works by blocking the activity of a specific protein called Bruton’s tyrosine kinase, or BTK. Bruton’s tyrosine kinase is a protein found in your B cells. It sends “signals” that help B cells to survive and multiply. By blocking BTK, this generic medicine helps kill and reduce the number of cancerous B-cells. This stops or slows the progression of cancer. In the case of cGVHD, BTK can cause your immune system cells to grow in number. And too many immune system cells can cause your cGVHD to get worse. This medication blocks the immune cells from reproducing, which eases your symptoms of cGVHD.
You should take it according to your doctor’s or healthcare provider’s instructions. Depending on the condition being treated, different dosages of Tybriva 140mg capsule may be prescribed. This medication is usually taken once a day with or without food. There’s no recommendation for an exact time of day that you should take this cancer drug. But try to constantly take the medicine every day at about the same time each day.
It shouldn’t be crushed, split, or chewed. Talk with your doctor or pharmacist about how to safely handle Emcure ibrutinib while you’re taking it. And if you have trouble swallowing capsules, talk with your healthcare provider about safe ways to make doing so easier for you.
Tybriva 140 mg begins blocking the reproduction of cancer cells or overactive immune cells after your first dose. You should keep taking it each day unless your condition gets worse or if you have side effects from taking the medication. Never stop taking it without first talking to your doctor. Depending on the type of cancer you have, your doctor may order certain tests to see if Tybriva is working for you. In some cases, this may include certain blood or imaging tests.
• Decreased appetite
• Trouble breathing
• Pain in your muscles or joints
• Mild allergic reaction, such as skin rash; itchiness, and flushing (warmth and redness in your skin)
• Urinary tract infections
• Mouth sores (stomatitis)
The safety of this medicine hasn’t been studied in pregnant women. However, in animal studies, this oral oncology drug has been shown to cause birth defects such as bone problems. But keep in mind that the results of animal studies don’t always predict what will happen in people. Because of the possible risks, it’s recommended that you don’t use Tybriva 140 mg (Ibrutinib) if you’re pregnant.
If you’re pregnant or planning to become pregnant, talk with your doctor before using generic Imbruvica. They can help you decide how to manage your treatment.
It’s not known if the medicine passes into breast milk or if it’s safe for a breastfed child. If you’re breastfeeding, it’s important to talk with your doctor before you start to take Tybriva capsules. They can discuss with you safe and healthy ways to feed your child.
This drug comes with several precautions. Before taking it, talk with your healthcare provider about your health history. This medicine may not be right for you if you have certain medical conditions or other factors affecting your health. These include:
• Bleeding problems
• Heart rhythm problems
• Increased cholesterol levels
• High blood pressure
• Liver problems
• Allergic reaction
• Kidney problems
Store Tybriva (Emcure Ibrutinib 140 mg) at room temperature 20°C to 25°C (68°F to 77°F). Excursions are permitted between 15°C and 30°C (59°F to 86°F).
Drugssquare is an authorized retailer, exporter, and supplier of Tybriva 140 mg Ibrutinib capsules in USA (United States of America), United Arab Emirates, UK (United Kingdom), Philippines, China, Hong Kong, Australia, Russia, Malaysia, Thailand, South Africa, Saudi Arabia, Nigeria, South Korea, Chile, Japan, Bangladesh, and other countries. We put patients first. If you want to purchase low-cost Emcure Tybriva 140mg (generic Imbruvica), place an order online with us today and we will deliver it directly to your door. Our specialty pharmacy strives to improve the lives of patients with blood cancer by providing generic blood cancer medications with huge discounts and special offers. Follow these few simple steps to order your medicines online without any hassle -
2. Select the quantity and add the product to the cart.
3. Upload prescription & complete the checkout process.
4. Confirm your order and pay your bill online.
5. Once payment is received, we will send your medication to the shipping address you provided.
In order to legally purchase this medicine from DrugsSquare, you’ll require a prescription from your Registered Medical Practitioner.
All content found on Drugssquare.com, including text, images, or other formats, is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always consult your doctor or other qualified health professionals if you have any questions regarding your health, medicine, or medical condition. This pharmacy is present to deliver, supply, export, or dispense prescription and OTC medicines online directly to consumers/patients.